​

Alzamend Neuro Ownership | Who Owns Alzamend Neuro?

OverviewRevenueFinancialsChart

Alzamend Neuro Ownership Summary

Alzamend Neuro is owned by 6.35% institutional investors, and 93.65% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.18% of its assets in Alzamend Neuro shares.

ALZN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAlzamend Neuro6.35%-93.65%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2023244.35%6,248,4241.95%616.34%11120.00%2-60.00%
Jun 30, 202323-23.33%6,128,982-1.26%615.64%5-16.67%5-37.50%
Mar 31, 202330-14.29%6,207,291-10.82%612.60%6-71.43%814.29%
Dec 31, 202235105.88%6,960,481-12.10%710.73%21162.50%775.00%
Sep 30, 202217-29.17%7,918,843157.44%881.58%8-20.00%4-33.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr7.85K0.18%-
Fidelity Extended Market Index3.92K0.09%1.54K
Fidelity Nasdaq Composite Index1.27K0.03%-
Fidelity Total Market Index705.000.02%-
Fidelity Series Total Market Index587.000.01%-
NT Ext Equity Mkt Idx Fd - NL374.000.01%-1.00
NT Ext Equity Mkt Idx Fd - DC - NL - T2301.000.01%-
NT Ext Equity Mkt Idx Fd - L286.000.01%-
Northern Trust Extended Eq Market Idx286.000.01%-
Spartan Total Market Index Pool E260.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 06, 2024AULT MILTON C III Buy$206.25
Jul 31, 2024AULT MILTON C III Buy$93.42
Apr 19, 2024AULT MILTON C III Buy$688.20
Apr 01, 2024AULT MILTON C III Buy$304.24
Jan 05, 2024AULT MILTON C III Buy$2.13K

Insider Transactions Trends

DateBuySell
2024 Q31-
2024 Q22-
2024 Q16-
2023 Q42-
2023 Q31-

ALZN Ownership FAQ

Who Owns Alzamend Neuro?

Alzamend Neuro shareholders are primarily institutional investors at 6.35%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Alzamend Neuro's industry, Biotech Stocks , is 47.04%, which Alzamend Neuro falls below.

Does Blackrock own Alzamend Neuro?

BlackRock is not among the top 10 institutional shareholders of Alzamend Neuro.

Who is the top mutual fund holder of Alzamend Neuro shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Alzamend Neuro shares, with 0.18% of its total shares outstanding invested in 7.85K Alzamend Neuro shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools